Fassnacht, Martin <br/><br/>
Combination chemotherapy in advanced adrenocortical carcinoma.  [electronic resource] 

 -  The New England journal of medicine  Jun 2012 
 - 2189-97 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1200966  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Neoplasms--drug therapy<br/>Adrenocortical Carcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Intention to Treat Analysis<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Mitotane--administration & dosage<br/>Quality of Life<br/>Streptozocin--administration & dosage<br/>Young Adult